Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Primary cytomegalovirus infection with invasive disease in a patient with inflammatory bowel disease.

Gong J, Meyerowitz EA, Isidro RA, Kaye KM.

BMJ Case Rep. 2019 Sep 30;12(9). pii: e230056. doi: 10.1136/bcr-2019-230056.

PMID:
31570344
2.

NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.

Zhang F, Liang D, Lin X, Zou Z, Sun R, Wang X, Liang X, Kaye KM, Lan K.

PLoS Pathog. 2019 Feb 27;15(2):e1007628. doi: 10.1371/journal.ppat.1007628. eCollection 2019 Feb.

3.

Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.

Juillard F, De León Vázquez E, Tan M, Li S, Kaye KM.

J Virol. 2019 Mar 5;93(6). pii: e02158-18. doi: 10.1128/JVI.02158-18. Print 2019 Mar 15.

4.

In Vivo Persistence of Chimeric Virus after Substitution of the Kaposi's Sarcoma-Associated Herpesvirus LANA DNA Binding Domain with That of Murid Herpesvirus 4.

Pires de Miranda M, Quendera AP, McVey CE, Kaye KM, Simas JP.

J Virol. 2018 Oct 12;92(21). pii: e01251-18. doi: 10.1128/JVI.01251-18. Print 2018 Nov 1.

5.

Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA.

Habison AC, de Miranda MP, Beauchemin C, Tan M, Cerqueira SA, Correia B, Ponnusamy R, Usherwood EJ, McVey CE, Simas JP, Kaye KM.

PLoS Pathog. 2017 Sep 14;13(9):e1006555. doi: 10.1371/journal.ppat.1006555. eCollection 2017 Sep.

6.

Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.

Nayar U, Sadek J, Reichel J, Hernandez-Hopkins D, Akar G, Barelli PJ, Sahai MA, Zhou H, Totonchy J, Jayabalan D, Niesvizky R, Guasparri I, Hassane D, Liu Y, Sei S, Shoemaker RH, Warren JD, Elemento O, Kaye KM, Cesarman E.

J Clin Invest. 2017 Jun 1;127(6):2066-2080. doi: 10.1172/JCI83936. Epub 2017 May 15.

7.

Order of magnitude increase in photocatalytic rate for hierarchically porous anatase thin films synthesized from zinc titanate coatings.

Platt NJ, Kaye KM, Limburn GJ, Cosham SD, Kulak AN, Palgrave RG, Hyett G.

Dalton Trans. 2017 Feb 14;46(6):1975-1985. doi: 10.1039/c6dt04431j.

PMID:
28112304
8.

3-D Microwell Array System for Culturing Virus Infected Tumor Cells.

El Assal R, Gurkan UA, Chen P, Juillard F, Tocchio A, Chinnasamy T, Beauchemin C, Unluisler S, Canikyan S, Holman A, Srivatsa S, Kaye KM, Demirci U.

Sci Rep. 2016 Dec 22;6:39144. doi: 10.1038/srep39144.

9.

Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation.

Liang J, Zhou H, Gerdt C, Tan M, Colson T, Kaye KM, Kieff E, Zhao B.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14121-14126. Epub 2016 Nov 18.

10.

Kaposi's Sarcoma Herpesvirus Genome Persistence.

Juillard F, Tan M, Li S, Kaye KM.

Front Microbiol. 2016 Aug 12;7:1149. doi: 10.3389/fmicb.2016.01149. eCollection 2016. Review.

11.

Latency-Associated Nuclear Antigen E3 Ubiquitin Ligase Activity Impacts Gammaherpesvirus-Driven Germinal Center B Cell Proliferation.

Cerqueira SA, Tan M, Li S, Juillard F, McVey CE, Kaye KM, Simas JP.

J Virol. 2016 Aug 12;90(17):7667-83. doi: 10.1128/JVI.00813-16. Print 2016 Sep 1.

12.

Electrical response of a B lymphoma cell line latently infected with Kaposi's sarcoma herpesvirus.

Safavieh M, Khetani S, Juillard F, Kaul V, Kanakasabapathy MK, Kaye KM, Shafiee H.

Biosens Bioelectron. 2016 Jun 15;80:230-236. doi: 10.1016/j.bios.2016.01.060. Epub 2016 Jan 26.

13.

KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Ponnusamy R, Petoukhov MV, Correia B, Custodio TF, Juillard F, Tan M, Pires de Miranda M, Carrondo MA, Simas JP, Kaye KM, Svergun DI, McVey CE.

Nucleic Acids Res. 2015 Nov 16;43(20):10039-54. doi: 10.1093/nar/gkv987. Epub 2015 Sep 30.

14.

The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.

Li S, Tan M, Juillard F, Ponnusamy R, Correia B, Simas JP, Carrondo MA, McVey CE, Kaye KM.

J Biol Chem. 2015 Nov 20;290(47):28084-96. doi: 10.1074/jbc.M115.674622. Epub 2015 Sep 29.

15.

Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.

Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4354-63. doi: 10.1073/pnas.1510824112. Epub 2015 Jul 20.

16.

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva.

Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U.

Sci Rep. 2015 Jun 5;5:9919. doi: 10.1038/srep09919.

17.

Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Hu Z, Blackman MA, Kaye KM, Usherwood EJ.

J Immunol. 2015 Mar 15;194(6):2746-56. doi: 10.4049/jimmunol.1401928. Epub 2015 Feb 6.

18.

Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.

Beauchemin C, Moerke NJ, Faloon P, Kaye KM.

J Biomol Screen. 2014 Jul;19(6):947-58. doi: 10.1177/1087057114520973. Epub 2014 Feb 11.

19.

A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.

De León Vázquez E, Juillard F, Rosner B, Kaye KM.

Virology. 2014 Jan 5;448:344-55. doi: 10.1016/j.virol.2013.10.026. Epub 2013 Nov 12.

20.

Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.

Correia B, Cerqueira SA, Beauchemin C, Pires de Miranda M, Li S, Ponnusamy R, Rodrigues L, Schneider TR, Carrondo MA, Kaye KM, Simas JP, McVey CE.

PLoS Pathog. 2013;9(10):e1003673. doi: 10.1371/journal.ppat.1003673. Epub 2013 Oct 17.

21.

Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Vázquez Ede L, Carey VJ, Kaye KM.

J Virol. 2013 Nov;87(22):12270-83. doi: 10.1128/JVI.01243-13. Epub 2013 Sep 4.

22.

Stabilization of Myc through heterotypic poly-ubiquitination by mLANA is critical for γ-herpesvirus lymphoproliferation.

Rodrigues L, Popov N, Kaye KM, Simas JP.

PLoS Pathog. 2013;9(8):e1003554. doi: 10.1371/journal.ppat.1003554. Epub 2013 Aug 8.

23.

Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability.

Dheekollu J, Chen HS, Kaye KM, Lieberman PM.

J Virol. 2013 Apr;87(7):3699-709. doi: 10.1128/JVI.02211-12. Epub 2013 Jan 16.

24.

Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence.

Habison AC, Beauchemin C, Simas JP, Usherwood EJ, Kaye KM.

J Virol. 2012 Nov;86(21):11863-76. doi: 10.1128/JVI.01656-12. Epub 2012 Aug 22.

25.

The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Ballestas ME, Kaye KM.

Future Microbiol. 2011 Dec;6(12):1399-413. doi: 10.2217/fmb.11.137. Review.

26.

Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime.

Bazan JA, Martin SI, Kaye KM.

Med Clin North Am. 2011 Jul;95(4):743-60, viii. doi: 10.1016/j.mcna.2011.03.009.

PMID:
21679790
27.

The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence.

De León Vázquez E, Kaye KM.

J Virol. 2011 Aug;85(15):7622-33. doi: 10.1128/JVI.00304-11. Epub 2011 May 18.

28.

Rapid and quantitative assessment of KSHV LANA-mediated DNA replication.

De León Vázquez E, Kaye KM.

Arch Virol. 2011 Aug;156(8):1323-33. doi: 10.1007/s00705-011-0985-0. Epub 2011 Apr 7.

29.

Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime.

Bazan JA, Martin SI, Kaye KM.

Infect Dis Clin North Am. 2009 Dec;23(4):983-96, ix. doi: 10.1016/j.idc.2009.06.007. Review.

PMID:
19909894
30.

Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.

Kelley-Clarke B, De Leon-Vazquez E, Slain K, Barbera AJ, Kaye KM.

J Virol. 2009 May;83(9):4326-37. doi: 10.1128/JVI.02395-08. Epub 2009 Feb 18.

31.

KSHV LANA's expanding bag of tricks.

Barbera AJ, Kaye KM.

Blood. 2008 May 1;111(9):4425-6. doi: 10.1182/blood-2008-02-136036. No abstract available.

32.

A charged and contoured surface on the nucleosome regulates chromatin compaction.

Chodaparambil JV, Barbera AJ, Lu X, Kaye KM, Hansen JC, Luger K.

Nat Struct Mol Biol. 2007 Nov;14(11):1105-7. Epub 2007 Oct 28.

33.

Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Bihl F, Narayan M, Chisholm JV 3rd, Henry LM, Suscovich TJ, Brown EE, Welzel TM, Kaufmann DE, Zaman TM, Dollard S, Martin JN, Wang F, Scadden DT, Kaye KM, Brander C.

J Virol. 2007 May;81(9):4904-8. Epub 2007 Feb 28.

34.

Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.

Kelley-Clarke B, Ballestas ME, Srinivasan V, Barbera AJ, Komatsu T, Harris TA, Kazanjian M, Kaye KM.

J Virol. 2007 Apr;81(8):4348-56. Epub 2007 Feb 7.

35.

Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.

Kelley-Clarke B, Ballestas ME, Komatsu T, Kaye KM.

Virology. 2007 Jan 20;357(2):149-57. Epub 2006 Sep 18.

36.

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.

You J, Srinivasan V, Denis GV, Harrington WJ Jr, Ballestas ME, Kaye KM, Howley PM.

J Virol. 2006 Sep;80(18):8909-19.

37.

Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.

Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Luger K, Kaye KM.

Cell Cycle. 2006 May;5(10):1048-52. Epub 2006 May 15.

PMID:
16721045
38.

The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.

Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, Luger K, Kaye KM.

Science. 2006 Feb 10;311(5762):856-61.

39.
40.

Beta-lactam antibiotics: newer formulations and newer agents.

Martin SI, Kaye KM.

Infect Dis Clin North Am. 2004 Sep;18(3):603-19, ix. Review.

PMID:
15308278
41.
44.

The KSHV latency-associated nuclear antigen: a multifunctional protein.

Komatsu T, Ballestas ME, Barbera AJ, Kaye KM.

Front Biosci. 2002 Mar 1;7:d726-30. Review.

PMID:
11861213
45.

The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.

Komatsu T, Barbera AJ, Ballestas ME, Kaye KM.

Viral Immunol. 2001;14(4):311-7. Review.

PMID:
11792061
47.

Once-daily dosing of aminoglycoside antibiotics.

Fisman DN, Kaye KM.

Infect Dis Clin North Am. 2000 Jun;14(2):475-87. Review.

PMID:
10829267
48.

An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.

Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E.

J Virol. 1999 Dec;73(12):10525-30.

49.

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Ballestas ME, Chatis PA, Kaye KM.

Science. 1999 Apr 23;284(5414):641-4.

50.

Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.

Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC.

N Engl J Med. 1998 Aug 13;339(7):444-9. No abstract available.

Supplemental Content

Support Center